• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当分次放疗期间正常组织恢复不完全时,线性二次模型在分次放疗中的应用,以及对每天多次分次治疗的潜在影响。

The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day.

作者信息

Dale R G

出版信息

Br J Radiol. 1986 Sep;59(705):919-27. doi: 10.1259/0007-1285-59-705-919.

DOI:10.1259/0007-1285-59-705-919
PMID:3756389
Abstract

By extending a previously developed mathematical model based on the linear-quadratic dose-effect relationship, it is possible to examine the consequences of performing fractionated treatments for which there is insufficient time between fractions to allow complete damage repair. Equations are derived which give the relative effectiveness of such treatments in terms of tissue-repair constants (mu values) and alpha/beta ratios, and these are then applied to some examples of treatments involving multiple fractions per day. The interplay of the various mechanisms involved (including repopulation effects) and their possible influence on treatments involving closely spaced fractions are examined. If current indications of the differences in recovery rates between early- and late-reacting normal tissues are representative, then it is shown that such differences may limit the clinical potential of accelerated fractionation regimes, where several fractions per day are given in a relatively short overall time.

摘要

通过扩展先前基于线性二次剂量效应关系开发的数学模型,可以研究进行分次治疗的后果,即分次之间没有足够时间让损伤完全修复的情况。推导了一些方程,这些方程根据组织修复常数(μ值)和α/β比值给出了此类治疗的相对有效性,然后将其应用于一些每天进行多次分次治疗的示例中。研究了各种相关机制(包括再增殖效应)之间的相互作用及其对间隔紧密的分次治疗可能产生的影响。如果目前关于早反应和晚反应正常组织恢复率差异的指标具有代表性,那么结果表明,这种差异可能会限制加速分次放疗方案的临床潜力,即在相对较短的总时间内每天给予多次分次照射的方案。

相似文献

1
The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day.当分次放疗期间正常组织恢复不完全时,线性二次模型在分次放疗中的应用,以及对每天多次分次治疗的潜在影响。
Br J Radiol. 1986 Sep;59(705):919-27. doi: 10.1259/0007-1285-59-705-919.
2
Derivation of the optimum dose per fraction from the linear quadratic model.从线性二次模型推导最佳分次剂量。
Br J Radiol. 1995 Aug;68(812):894-902. doi: 10.1259/0007-1285-68-812-894.
3
The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.线性二次剂量效应方程在分割和延长放疗中的应用。
Br J Radiol. 1985 Jun;58(690):515-28. doi: 10.1259/0007-1285-58-690-515.
4
A generalized formulation of the 'incomplete-repair' model for cell survival and tissue response to fractionated low dose-rate irradiation.细胞存活和组织对分次低剂量率照射反应的“不完全修复”模型的广义公式。
Int J Radiat Biol. 1990 Jan;57(1):127-42. doi: 10.1080/09553009014550401.
5
[Dose-time optimization in fractionated radiotherapy].[分次放射治疗中的剂量-时间优化]
Strahlenther Onkol. 1988 Aug;164(8):489-98.
6
An 'incomplete-repair' model for survival after fractionated and continuous irradiations.
Int J Radiat Biol Relat Stud Phys Chem Med. 1985 Mar;47(3):319-39. doi: 10.1080/09553008514550461.
7
Analysis of cell survival after multiple fractions per day and low-dose-rate irradiation of two in vitro cultured rat tumor cell lines.对两种体外培养的大鼠肿瘤细胞系进行每日多次分割及低剂量率照射后的细胞存活情况分析。
Radiat Res. 1985 Oct;104(1):28-46.
8
The influence of experimental design and data analysis on the determination of recovery kinetics of radiation damage between acute dose-rate treatments in vivo.实验设计和数据分析对体内急性剂量率处理之间辐射损伤恢复动力学测定的影响。
Int J Radiat Biol. 1990 Jan;57(1):143-62. doi: 10.1080/09553009014550411.
9
A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy.
Br J Radiol. 1986 Nov;59(707):1111-5. doi: 10.1259/0007-1285-59-707-1111.
10
An effective dose computation model for fractionated radiation dose.
Radiat Med. 1983 Apr-Jun;1(2):155-60.

引用本文的文献

1
Optimizing normal tissue sparing via spatiotemporal optimization under equivalent tumor-radical efficacy.在等效肿瘤根治疗效下,通过时空优化实现正常组织保护的最大化。
ArXiv. 2025 Sep 5:arXiv:2502.16333v2.
2
Multi-IMPT: a biologically equivalent approach to proton ARC therapy.多影像引导调强质子治疗:一种与质子弧形治疗生物学等效的方法。
ArXiv. 2024 Nov 26:arXiv:2411.17578v1.
3
Radiotherapy treatment interruptions during the Covid-19 pandemic: The UK experience and implications for radiobiology training.新冠疫情期间放疗治疗中断:英国的经验及对放射生物学培训的影响
Radiat Phys Chem Oxf Engl 1993. 2022 Nov;200:110214. doi: 10.1016/j.radphyschem.2022.110214. Epub 2022 May 6.
4
Total body irradiation of bone marrow transplant using helical TomoTherapy with a focus on the quality of dose contribution at junction target volumes.全身骨髓移植的螺旋断层放疗,重点关注在靶区交接处剂量贡献的质量。
Strahlenther Onkol. 2021 Aug;197(8):722-729. doi: 10.1007/s00066-021-01769-2. Epub 2021 Apr 14.
5
Predicting acute odynophagia during lung cancer radiotherapy using observations derived from patient-centred nursing care.利用以患者为中心的护理观察结果预测肺癌放疗期间的急性吞咽痛
Tech Innov Patient Support Radiat Oncol. 2018 Feb 22;5:16-20. doi: 10.1016/j.tipsro.2018.01.002. eCollection 2018 Mar.
6
The evolution of practical radiobiological modelling.实用放射生物学建模的发展。
Br J Radiol. 2019 Jan;92(1093):20180097. doi: 10.1259/bjr.20180097. Epub 2018 Mar 20.
7
Clinical and histological features of second breast cancers following radiotherapy for childhood and young adult malignancy.儿童和青年恶性肿瘤放疗后第二原发性乳腺癌的临床和组织学特征
Br J Radiol. 2018 Jun;91(1086):20170824. doi: 10.1259/bjr.20170824. Epub 2018 Mar 15.
8
Radiation repair models for clinical application.用于临床应用的辐射修复模型。
Br J Radiol. 2019 Jan;92(1093):20180070. doi: 10.1259/bjr.20180070. Epub 2018 Feb 28.
9
Minimizing second cancer risk following radiotherapy: current perspectives.放疗后降低二次癌症风险:当前观点
Cancer Manag Res. 2014 Dec 17;7:1-11. doi: 10.2147/CMAR.S47220. eCollection 2015.
10
21 years of biologically effective dose.21 年的生物有效剂量。
Br J Radiol. 2010 Jul;83(991):554-68. doi: 10.1259/bjr/31372149.